Antiplatelet Drugs

Antiplatelet agents inhibit platelet activation and aggregation, the dominant event in arterial (white) thrombus formation. They are the backbone of primary and secondary prevention in coronary artery disease, ischaemic stroke and peripheral arterial disease, and are among the most heavily tested topics in NEET PG pharmacology for the cardiovascular system. Arterial thrombi are platelet-rich ("white thrombi"), for…